Prevention of hepatitis B virus reactivation in immunosuppressive therapy or chemotherapy.
about
Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelinesA case of anti-GBM glomerulonephritis superimposed on HBV-associated membranous nephropathyDe novo acute hepatitis B in myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody-related microscopic polyangiitis treated with corticosteroids.Changes in hepatitis B virus antibody titers over time among children: a single center study from 2012 to 2015 in an urban of South Korea.Concurrent infection of hepatitis B virus negatively affects the clinical outcome and prognosis of patients with non-Hodgkin's lymphoma after chemotherapyAnalysis of baseline hepatitis B virus DNA levels in chronic hepatitis B patients with non-hematological malignancies prior to the initiation of cancer chemotherapy.Acute hepatitis B virus infection or acute exacerbation of chronic hepatitis B infection: the differential serological diagnosis.Immunosuppression in Patients with Chronic Hepatitis B.Quantitative Proteomic Analysis Reveals That Arctigenin Alleviates Concanavalin A-Induced Hepatitis Through Suppressing Immune System and Regulating Autophagy
P2860
Q27000080-7DD3CE70-2FF1-4ADD-8578-46143E82395AQ33622153-2489E7B5-A9CF-40FD-AAC6-783187488E4EQ33628268-6BC7ED09-2DF7-4AF8-8DD6-BD7DC86FC698Q33908516-98392CDF-E4A2-40A0-BCC8-0B1427E5AC2AQ34828556-DBD35B4F-4C45-483C-B501-9AA51F58BEA0Q37001173-03686FFD-EE92-4F18-9955-E7C527C6D8CBQ38637664-FC2551E9-55A7-45E6-ABD5-3FA10486AFD9Q42764680-25DB25E5-BD17-4ECF-802B-FB308530DB21Q58773456-587CBFE3-D36D-44ED-8D6A-5421D317C202
P2860
Prevention of hepatitis B virus reactivation in immunosuppressive therapy or chemotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevention of hepatitis B viru ...... ssive therapy or chemotherapy.
@en
Prevention of hepatitis B viru ...... ssive therapy or chemotherapy.
@nl
type
label
Prevention of hepatitis B viru ...... ssive therapy or chemotherapy.
@en
Prevention of hepatitis B viru ...... ssive therapy or chemotherapy.
@nl
prefLabel
Prevention of hepatitis B viru ...... ssive therapy or chemotherapy.
@en
Prevention of hepatitis B viru ...... ssive therapy or chemotherapy.
@nl
P2860
P1476
Prevention of hepatitis B viru ...... ssive therapy or chemotherapy.
@en
P2093
Kazuaki Chayama
Waka Ohishi
P2860
P2888
P304
P356
10.1007/S10157-011-0464-7
P577
2011-06-01T00:00:00Z